These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28135835)
1. Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Sarris J Australas Psychiatry; 2017 Aug; 25(4):369-372. PubMed ID: 28135835 [TBL] [Abstract][Full Text] [Related]
2. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615 [TBL] [Abstract][Full Text] [Related]
3. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Sarris J; Mischoulon D; Schweitzer I Bipolar Disord; 2011; 13(5-6):454-65. PubMed ID: 22017215 [TBL] [Abstract][Full Text] [Related]
4. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Sarris J; Murphy J; Mischoulon D; Papakostas GI; Fava M; Berk M; Ng CH Am J Psychiatry; 2016 Jun; 173(6):575-87. PubMed ID: 27113121 [TBL] [Abstract][Full Text] [Related]
5. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders. Ciappolino V; Delvecchio G; Agostoni C; Mazzocchi A; Altamura AC; Brambilla P J Affect Disord; 2017 Dec; 224():32-47. PubMed ID: 28089169 [TBL] [Abstract][Full Text] [Related]
6. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. Martins JG J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549 [TBL] [Abstract][Full Text] [Related]
7. Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review. van der Burg KP; Cribb L; Firth J; Karmacoska D; Sarris J Nutr Neurosci; 2021 Apr; 24(4):279-295. PubMed ID: 31397223 [No Abstract] [Full Text] [Related]
8. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738 [TBL] [Abstract][Full Text] [Related]
11. Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Sarris J; Schoendorfer N; Kavanagh DJ Nutr Rev; 2009 Mar; 67(3):125-31. PubMed ID: 19239627 [TBL] [Abstract][Full Text] [Related]
12. The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials. Fusar-Poli L; Surace T; Vanella A; Meo V; Patania F; Furnari R; Signorelli MS; Aguglia E J Affect Disord; 2019 Jun; 252():334-349. PubMed ID: 30999090 [TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. Wozniak J; Faraone SV; Chan J; Tarko L; Hernandez M; Davis J; Woodworth KY; Biederman J J Clin Psychiatry; 2015 Nov; 76(11):1548-55. PubMed ID: 26646031 [TBL] [Abstract][Full Text] [Related]
14. Nutraceuticals in mood disorders: current knowledge and future directions. Travica N; Teasdale S; Marx W Curr Opin Psychiatry; 2023 Jan; 36(1):54-59. PubMed ID: 36044293 [TBL] [Abstract][Full Text] [Related]
16. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations. Sarris J; Lake J; Hoenders R J Altern Complement Med; 2011 Oct; 17(10):881-90. PubMed ID: 22010777 [TBL] [Abstract][Full Text] [Related]
17. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation]. Sempels C; Sienaert P Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373 [TBL] [Abstract][Full Text] [Related]
18. Nutrient-based therapies for bipolar disorder: a systematic review. Sylvia LG; Peters AT; Deckersbach T; Nierenberg AA Psychother Psychosom; 2013; 82(1):10-9. PubMed ID: 23147067 [TBL] [Abstract][Full Text] [Related]
19. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. Lin PY; Su KP J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis. Schefft C; Kilarski LL; Bschor T; Köhler S Eur Neuropsychopharmacol; 2017 Nov; 27(11):1090-1109. PubMed ID: 28988944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]